Literature DB >> 10601978

Variant estrogen receptor-alpha messenger RNA expression in hormone-independent human breast cancer cells.

A S Coutts1, E Leygue, L C Murphy.   

Abstract

T5-PRF cells are insensitive to the growth-stimulatory effects of estrogen while still retaining expression of estrogen receptor-alpha (ER-alpha). In the apparent absence of ligand, T5-PRF cells have a 3. 6+/-0.5 (s.e.m.)-fold increased basal ER-alpha activity and elevated basal progesterone receptor levels compared with the parent, estrogen-sensitive, T5 cells. Long-range ER-alpha reverse transcription-PCR was performed to characterize variant ER-alpha mRNA expression in the two cell lines. An increased relative expression of an exon 3/4-deleted ER-alpha mRNA variant was found in T5-PRF. Recombinant expression of this ER-alpha variant resulted in significantly increased estrogen responsiveness, as well as a trend to increased basal ligand-independent activity when expressed with wild-type ER-alpha in ER-negative cell lines, as well as significantly increasing both ligand-independent and estrogen-induced ER-alpha transcriptional activity when expressed in parental T5 cells. These results suggest a role for altered variant ER-alpha in ligand-independent activation of ER-alpha which may contribute to hormone independence in breast tumors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10601978     DOI: 10.1677/jme.0.0230325

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  2 in total

1.  Relationship between mammaglobin expression and estrogen receptor status in breast tumors.

Authors:  Xiao-feng Guan; Mohammad K Hamedani; Adewale Adeyinka; Christina Walker; Angela Kemp; Leigh C Murphy; Peter H Watson; Etienne Leygue
Journal:  Endocrine       Date:  2003-08       Impact factor: 3.633

2.  Selective association of peroxiredoxin 1 with genomic DNA and COX-2 upstream promoter elements in estrogen receptor negative breast cancer cells.

Authors:  Xuemei Wang; Shihua He; Jian-Min Sun; Geneviève P Delcuve; James R Davie
Journal:  Mol Biol Cell       Date:  2010-07-14       Impact factor: 4.138

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.